Open AccessNonfasting Apo-lipoprotein B & Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients
Author(s) -
Nayyer-Uz-Zaman,
Muhammad Habeel Dar,
Yasir Adnan,
Luboor,
Gul Naz,
Zahoor
Publication year - 2018
Publication title -
pakistan journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.316
H-Index - 30
eISSN - 1682-024X
pISSN - 1681-715X
DOI - 10.12669/pjms.342.13848
Subject(s) - medicine , myocardial infarction , diabetes mellitus , cardiology , risk factor , type 2 diabetes , coronary artery disease , triglyceride , heart disease , lipoprotein(a) , lipoprotein , cholesterol , endocrinology
Lipoprotein-A has been recognized as a risk factor for ischemic heart diseases. Myocardial infarction (MI) is common complication of ischemic heart disease. Diabetes play an incremental role in the development of coronary artery disease (CAD), however still there are conflicting data regarding the relationship of Lipoprotein-B and MI. We therefore wanted to evaluate the relationship of Lipo-B, MI and diabetes mellitus. Our objective was to determine the non-fasting Apo-lipoprotein B and triglycerides level among type II diabetic patients with ischemic heart disease and to compare with type II diabetic without ischemic heart disease.